Search Results Search Sort by RelevanceMost Recent Case and Commentary Jan 2005 Mr. Jones Keeps Calling, Option Assessment Faith Lagay, PhD Virtual Mentor. 2005;7(1):10-13. doi: 10.1001/virtualmentor.2005.7.1.ccas2a-0501. Case and Commentary Jan 2005 Mr. Jones Keeps Calling, Option Comparison Faith Lagay, PhD Virtual Mentor. 2005;7(1):10-13. doi: 10.1001/virtualmentor.2005.7.1.ccas2b-0501. Case and Commentary Jan 2005 Mr. Jones Keeps Calling, Additional Information Faith Lagay, PhD Virtual Mentor. 2005;7(1):10-13. doi: 10.1001/virtualmentor.2005.7.1.ccas2c-0501. Case and Commentary Jan 2005 Saying Goodbye to Mr. Jones, Option Assessment Jennifer Reenan, MD Virtual Mentor. 2005;7(1):18-22. doi: 10.1001/virtualmentor.2005.7.1.ccas4a-0501. Case and Commentary Jan 2005 Saying Goodbye to Mr. Jones, Option Comparison Jennifer Reenan, MD Virtual Mentor. 2005;7(1):18-22. doi: 10.1001/virtualmentor.2005.7.1.ccas4b-0501. Case and Commentary Jan 2005 Saying Goodbye to Mr. Jones, Additional Information Jennifer Reenan, MD Virtual Mentor. 2005;7(1):18-22. doi: 10.1001/virtualmentor.2005.7.1.ccas4c-0501. History of Medicine Dec 2011 The Evolution of Addiction Medicine as a Medical Specialty David E. Smith, MD The medicalization of addiction has greatly improved identification, early intervention, and referral to appropriate treatment. Virtual Mentor. 2011;13(12):900-905. doi: 10.1001/virtualmentor.2011.13.12.mhst1-1112. State of the Art and Science Mar 2009 Type 2 Diabetes: Lifestyle Changes and Drug Treatment Natalie A. Brooks, PharmD The principal therapies for type 2 diabetes and the benefits and possible side effects associated with each. Virtual Mentor. 2009;11(3):237-241. doi: 10.1001/virtualmentor.2009.11.3.cprl1-0903. Case and Commentary May 2002 Drug Marketing and Patient Consent Erica Ozanne Linden, JD, MPH An ethical case describes the use of a pharmacy's database to market directly to their patients without either patient consent or disclosure of the marketing intent of the materials they received. Virtual Mentor. 2002;4(5):136-137. doi: 10.1001/virtualmentor.2002.4.5.hlaw1-0205. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2
Case and Commentary Jan 2005 Mr. Jones Keeps Calling, Option Assessment Faith Lagay, PhD Virtual Mentor. 2005;7(1):10-13. doi: 10.1001/virtualmentor.2005.7.1.ccas2a-0501.
Case and Commentary Jan 2005 Mr. Jones Keeps Calling, Option Comparison Faith Lagay, PhD Virtual Mentor. 2005;7(1):10-13. doi: 10.1001/virtualmentor.2005.7.1.ccas2b-0501.
Case and Commentary Jan 2005 Mr. Jones Keeps Calling, Additional Information Faith Lagay, PhD Virtual Mentor. 2005;7(1):10-13. doi: 10.1001/virtualmentor.2005.7.1.ccas2c-0501.
Case and Commentary Jan 2005 Saying Goodbye to Mr. Jones, Option Assessment Jennifer Reenan, MD Virtual Mentor. 2005;7(1):18-22. doi: 10.1001/virtualmentor.2005.7.1.ccas4a-0501.
Case and Commentary Jan 2005 Saying Goodbye to Mr. Jones, Option Comparison Jennifer Reenan, MD Virtual Mentor. 2005;7(1):18-22. doi: 10.1001/virtualmentor.2005.7.1.ccas4b-0501.
Case and Commentary Jan 2005 Saying Goodbye to Mr. Jones, Additional Information Jennifer Reenan, MD Virtual Mentor. 2005;7(1):18-22. doi: 10.1001/virtualmentor.2005.7.1.ccas4c-0501.
History of Medicine Dec 2011 The Evolution of Addiction Medicine as a Medical Specialty David E. Smith, MD The medicalization of addiction has greatly improved identification, early intervention, and referral to appropriate treatment. Virtual Mentor. 2011;13(12):900-905. doi: 10.1001/virtualmentor.2011.13.12.mhst1-1112.
State of the Art and Science Mar 2009 Type 2 Diabetes: Lifestyle Changes and Drug Treatment Natalie A. Brooks, PharmD The principal therapies for type 2 diabetes and the benefits and possible side effects associated with each. Virtual Mentor. 2009;11(3):237-241. doi: 10.1001/virtualmentor.2009.11.3.cprl1-0903.
Case and Commentary May 2002 Drug Marketing and Patient Consent Erica Ozanne Linden, JD, MPH An ethical case describes the use of a pharmacy's database to market directly to their patients without either patient consent or disclosure of the marketing intent of the materials they received. Virtual Mentor. 2002;4(5):136-137. doi: 10.1001/virtualmentor.2002.4.5.hlaw1-0205.